drugset / Trial / NCT05999435
Study of LAU-7b for the Treatment of Long COVID in Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
ESSOR is a double-blind, placebo-controlled study of the orally-administered antiviral and inflammation-controlling LAU-7b for the treatment of adults with Long COVID and moderate to severe symptoms.
Timeline
- Start
- 2023-11-15
- Primary completion
- 2024-08-05
- Completion
- 2024-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fenretinide | Small molecule | — | Oral |